Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum.
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects.
Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.
[Action of cephalothin on the blood "in vitro": influence of some plasmatic components on the sensitivity of the erythrocytes to the drug].
Receptor for complement components and xenogeneic erythrocytes on human T- and B-lymphoid cells.
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells.
Antigen processing and HLA-peptide complexes in head and neck cancer
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
HLA Expression in Cancer
HLA CLASS I PEPTIDE COMPLEX ADNORMALITIES IN MELANOMA
Differential gene regulation of WT1 protein tumor antigen and the components of the antigen processing machinery by interferon-gamma signaling in myeloid leukemia.
ROLE OF THE HLA ANTIGEN PRESENTING MACHINERY (APM) IN RESISTANCE TO PD-1 AXIS BLOCKADE IN NON-SMALL CELL LUNG CANCER